nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—PTGS2—Risedronate—osteoporosis	0.438	0.79	CbGbCtD
Tolmetin—SLC22A6—Conjugated Estrogens—osteoporosis	0.116	0.21	CbGbCtD
Tolmetin—Anaphylactoid reaction—Pamidronate—osteoporosis	0.00173	0.00587	CcSEcCtD
Tolmetin—Weight increased—Raloxifene—osteoporosis	0.0017	0.00576	CcSEcCtD
Tolmetin—Erythema multiforme—Etidronic acid—osteoporosis	0.00169	0.00572	CcSEcCtD
Tolmetin—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.00168	0.00568	CcSEcCtD
Tolmetin—Weight decreased—Ibandronate—osteoporosis	0.00168	0.00567	CcSEcCtD
Tolmetin—Constipation—Calcium Acetate—osteoporosis	0.00165	0.0056	CcSEcCtD
Tolmetin—Stomatitis—Alendronate—osteoporosis	0.00165	0.0056	CcSEcCtD
Tolmetin—Weight decreased—Calcitriol—osteoporosis	0.00164	0.00555	CcSEcCtD
Tolmetin—Cardiac failure congestive—Conjugated Estrogens—osteoporosis	0.00163	0.00551	CcSEcCtD
Tolmetin—Blood pressure increased—Estradiol—osteoporosis	0.00163	0.00551	CcSEcCtD
Tolmetin—Renal failure—Ibandronate—osteoporosis	0.00162	0.0055	CcSEcCtD
Tolmetin—Urinary tract infection—Raloxifene—osteoporosis	0.00162	0.00549	CcSEcCtD
Tolmetin—Drowsiness—Calcitriol—osteoporosis	0.00162	0.00547	CcSEcCtD
Tolmetin—Stomatitis—Ibandronate—osteoporosis	0.00161	0.00545	CcSEcCtD
Tolmetin—Urinary tract infection—Ibandronate—osteoporosis	0.00161	0.00544	CcSEcCtD
Tolmetin—Urinary tract infection—Calcitriol—osteoporosis	0.00157	0.00532	CcSEcCtD
Tolmetin—Gastritis—Risedronate—osteoporosis	0.00156	0.00529	CcSEcCtD
Tolmetin—Visual disturbance—Conjugated Estrogens—osteoporosis	0.00156	0.00528	CcSEcCtD
Tolmetin—Flatulence—Etidronic acid—osteoporosis	0.00153	0.00519	CcSEcCtD
Tolmetin—Purpura—Conjugated Estrogens—osteoporosis	0.00153	0.00519	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Conjugated Estrogens—osteoporosis	0.00153	0.00517	CcSEcCtD
Tolmetin—Visual impairment—Estropipate—osteoporosis	0.00149	0.00504	CcSEcCtD
Tolmetin—Gastritis—Pamidronate—osteoporosis	0.00149	0.00503	CcSEcCtD
Tolmetin—Dysuria—Ethinyl Estradiol—osteoporosis	0.00146	0.00496	CcSEcCtD
Tolmetin—Abdominal discomfort—Risedronate—osteoporosis	0.00146	0.00495	CcSEcCtD
Tolmetin—Erythema multiforme—Estropipate—osteoporosis	0.00146	0.00495	CcSEcCtD
Tolmetin—Constipation—Ergocalciferol—osteoporosis	0.00146	0.00495	CcSEcCtD
Tolmetin—Erythema multiforme—Alendronate—osteoporosis	0.00144	0.00487	CcSEcCtD
Tolmetin—Weight increased—Ethinyl Estradiol—osteoporosis	0.00142	0.00482	CcSEcCtD
Tolmetin—Weight decreased—Ethinyl Estradiol—osteoporosis	0.00142	0.0048	CcSEcCtD
Tolmetin—Asthenia—Calcium Acetate—osteoporosis	0.00139	0.0047	CcSEcCtD
Tolmetin—Lymphadenopathy—Estradiol—osteoporosis	0.00138	0.00469	CcSEcCtD
Tolmetin—Erythema multiforme—Calcitriol—osteoporosis	0.00137	0.00465	CcSEcCtD
Tolmetin—Gastritis—Zoledronate—osteoporosis	0.00136	0.0046	CcSEcCtD
Tolmetin—Urinary tract infection—Ethinyl Estradiol—osteoporosis	0.00136	0.00459	CcSEcCtD
Tolmetin—Flatulence—Estropipate—osteoporosis	0.00133	0.00449	CcSEcCtD
Tolmetin—Diarrhoea—Calcium Acetate—osteoporosis	0.00132	0.00448	CcSEcCtD
Tolmetin—Urinary tract infection—Risedronate—osteoporosis	0.00132	0.00448	CcSEcCtD
Tolmetin—Vascular purpura—Estradiol—osteoporosis	0.00132	0.00447	CcSEcCtD
Tolmetin—Flatulence—Alendronate—osteoporosis	0.00131	0.00442	CcSEcCtD
Tolmetin—Flatulence—Raloxifene—osteoporosis	0.00128	0.00435	CcSEcCtD
Tolmetin—Dizziness—Calcium Acetate—osteoporosis	0.00128	0.00433	CcSEcCtD
Tolmetin—Renal failure—Pamidronate—osteoporosis	0.00127	0.00431	CcSEcCtD
Tolmetin—Flatulence—Ibandronate—osteoporosis	0.00127	0.00431	CcSEcCtD
Tolmetin—Abdominal discomfort—Zoledronate—osteoporosis	0.00127	0.0043	CcSEcCtD
Tolmetin—Stomatitis—Pamidronate—osteoporosis	0.00126	0.00427	CcSEcCtD
Tolmetin—Urinary tract infection—Pamidronate—osteoporosis	0.00126	0.00426	CcSEcCtD
Tolmetin—Visual disturbance—Estradiol—osteoporosis	0.00125	0.00422	CcSEcCtD
Tolmetin—Haematuria—Pamidronate—osteoporosis	0.00123	0.00418	CcSEcCtD
Tolmetin—Vomiting—Calcium Acetate—osteoporosis	0.00123	0.00416	CcSEcCtD
Tolmetin—Purpura—Estradiol—osteoporosis	0.00123	0.00415	CcSEcCtD
Tolmetin—Asthenia—Ergocalciferol—osteoporosis	0.00123	0.00415	CcSEcCtD
Tolmetin—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00122	0.00414	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Estradiol—osteoporosis	0.00122	0.00413	CcSEcCtD
Tolmetin—Visual impairment—Ethinyl Estradiol—osteoporosis	0.00121	0.00409	CcSEcCtD
Tolmetin—Agranulocytosis—Pamidronate—osteoporosis	0.00121	0.00409	CcSEcCtD
Tolmetin—Weight increased—Zoledronate—osteoporosis	0.00121	0.00408	CcSEcCtD
Tolmetin—Weight decreased—Zoledronate—osteoporosis	0.0012	0.00406	CcSEcCtD
Tolmetin—Dysuria—Conjugated Estrogens—osteoporosis	0.00119	0.00404	CcSEcCtD
Tolmetin—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00118	0.00401	CcSEcCtD
Tolmetin—Renal failure—Zoledronate—osteoporosis	0.00116	0.00393	CcSEcCtD
Tolmetin—Weight increased—Conjugated Estrogens—osteoporosis	0.00116	0.00393	CcSEcCtD
Tolmetin—Stomatitis—Zoledronate—osteoporosis	0.00115	0.0039	CcSEcCtD
Tolmetin—Urinary tract infection—Zoledronate—osteoporosis	0.00115	0.00389	CcSEcCtD
Tolmetin—Nausea—Calcium Acetate—osteoporosis	0.00115	0.00389	CcSEcCtD
Tolmetin—Tinnitus—Risedronate—osteoporosis	0.00114	0.00386	CcSEcCtD
Tolmetin—Chest pain—Alendronate—osteoporosis	0.00113	0.00382	CcSEcCtD
Tolmetin—Haematuria—Zoledronate—osteoporosis	0.00113	0.00382	CcSEcCtD
Tolmetin—Renal failure—Conjugated Estrogens—osteoporosis	0.00112	0.00379	CcSEcCtD
Tolmetin—Dyspepsia—Etidronic acid—osteoporosis	0.00112	0.00378	CcSEcCtD
Tolmetin—Chest pain—Raloxifene—osteoporosis	0.00111	0.00376	CcSEcCtD
Tolmetin—Agranulocytosis—Zoledronate—osteoporosis	0.0011	0.00373	CcSEcCtD
Tolmetin—Chest pain—Ibandronate—osteoporosis	0.0011	0.00372	CcSEcCtD
Tolmetin—Oedema—Estropipate—osteoporosis	0.0011	0.00372	CcSEcCtD
Tolmetin—Anaphylactic shock—Estropipate—osteoporosis	0.0011	0.00372	CcSEcCtD
Tolmetin—Constipation—Etidronic acid—osteoporosis	0.00109	0.00368	CcSEcCtD
Tolmetin—Chest pain—Calcitriol—osteoporosis	0.00108	0.00364	CcSEcCtD
Tolmetin—Anaphylactic shock—Ibandronate—osteoporosis	0.00105	0.00357	CcSEcCtD
Tolmetin—Flatulence—Risedronate—osteoporosis	0.00105	0.00355	CcSEcCtD
Tolmetin—Gastritis—Estradiol—osteoporosis	0.00105	0.00354	CcSEcCtD
Tolmetin—Thrombocytopenia—Raloxifene—osteoporosis	0.00104	0.00353	CcSEcCtD
Tolmetin—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00104	0.00352	CcSEcCtD
Tolmetin—Anaphylactic shock—Calcitriol—osteoporosis	0.00103	0.00349	CcSEcCtD
Tolmetin—Nausea—Ergocalciferol—osteoporosis	0.00101	0.00344	CcSEcCtD
Tolmetin—Urticaria—Etidronic acid—osteoporosis	0.00101	0.00341	CcSEcCtD
Tolmetin—Abdominal pain—Etidronic acid—osteoporosis	0.001	0.0034	CcSEcCtD
Tolmetin—Visual impairment—Conjugated Estrogens—osteoporosis	0.000984	0.00333	CcSEcCtD
Tolmetin—Abdominal discomfort—Estradiol—osteoporosis	0.000979	0.00332	CcSEcCtD
Tolmetin—Somnolence—Estropipate—osteoporosis	0.000976	0.00331	CcSEcCtD
Tolmetin—Dyspepsia—Estropipate—osteoporosis	0.000967	0.00327	CcSEcCtD
Tolmetin—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000966	0.00327	CcSEcCtD
Tolmetin—Dyspepsia—Alendronate—osteoporosis	0.000952	0.00322	CcSEcCtD
Tolmetin—Constipation—Estropipate—osteoporosis	0.000939	0.00318	CcSEcCtD
Tolmetin—Dyspepsia—Raloxifene—osteoporosis	0.000936	0.00317	CcSEcCtD
Tolmetin—Weight increased—Estradiol—osteoporosis	0.000929	0.00315	CcSEcCtD
Tolmetin—Dyspepsia—Ibandronate—osteoporosis	0.000927	0.00314	CcSEcCtD
Tolmetin—Constipation—Alendronate—osteoporosis	0.000925	0.00313	CcSEcCtD
Tolmetin—Weight decreased—Estradiol—osteoporosis	0.000924	0.00313	CcSEcCtD
Tolmetin—Somnolence—Calcitriol—osteoporosis	0.000916	0.0031	CcSEcCtD
Tolmetin—Chest pain—Risedronate—osteoporosis	0.000905	0.00307	CcSEcCtD
Tolmetin—Constipation—Ibandronate—osteoporosis	0.000901	0.00305	CcSEcCtD
Tolmetin—Gastrointestinal pain—Estropipate—osteoporosis	0.000898	0.00304	CcSEcCtD
Tolmetin—Oedema—Ethinyl Estradiol—osteoporosis	0.00089	0.00301	CcSEcCtD
Tolmetin—Urinary tract infection—Estradiol—osteoporosis	0.000885	0.003	CcSEcCtD
Tolmetin—Gastrointestinal pain—Alendronate—osteoporosis	0.000885	0.003	CcSEcCtD
Tolmetin—Constipation—Calcitriol—osteoporosis	0.000882	0.00299	CcSEcCtD
Tolmetin—Flatulence—Conjugated Estrogens—osteoporosis	0.000876	0.00297	CcSEcCtD
Tolmetin—Urticaria—Estropipate—osteoporosis	0.000872	0.00295	CcSEcCtD
Tolmetin—Gastrointestinal pain—Raloxifene—osteoporosis	0.00087	0.00295	CcSEcCtD
Tolmetin—Diarrhoea—Etidronic acid—osteoporosis	0.000869	0.00294	CcSEcCtD
Tolmetin—Haematuria—Estradiol—osteoporosis	0.000868	0.00294	CcSEcCtD
Tolmetin—Abdominal pain—Estropipate—osteoporosis	0.000868	0.00294	CcSEcCtD
Tolmetin—Body temperature increased—Estropipate—osteoporosis	0.000868	0.00294	CcSEcCtD
Tolmetin—Gastrointestinal pain—Ibandronate—osteoporosis	0.000861	0.00292	CcSEcCtD
Tolmetin—Urticaria—Alendronate—osteoporosis	0.000859	0.00291	CcSEcCtD
Tolmetin—Epistaxis—Estradiol—osteoporosis	0.000859	0.00291	CcSEcCtD
Tolmetin—Abdominal pain—Alendronate—osteoporosis	0.000855	0.0029	CcSEcCtD
Tolmetin—Body temperature increased—Alendronate—osteoporosis	0.000855	0.0029	CcSEcCtD
Tolmetin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000843	0.00285	CcSEcCtD
Tolmetin—Abdominal pain—Raloxifene—osteoporosis	0.000841	0.00285	CcSEcCtD
Tolmetin—Body temperature increased—Raloxifene—osteoporosis	0.000841	0.00285	CcSEcCtD
Tolmetin—Urticaria—Ibandronate—osteoporosis	0.000837	0.00283	CcSEcCtD
Tolmetin—Abdominal pain—Ibandronate—osteoporosis	0.000833	0.00282	CcSEcCtD
Tolmetin—Body temperature increased—Ibandronate—osteoporosis	0.000833	0.00282	CcSEcCtD
Tolmetin—Anaphylactic shock—Pamidronate—osteoporosis	0.000825	0.00279	CcSEcCtD
Tolmetin—Oedema—Pamidronate—osteoporosis	0.000825	0.00279	CcSEcCtD
Tolmetin—Urticaria—Calcitriol—osteoporosis	0.000819	0.00277	CcSEcCtD
Tolmetin—Hepatitis—Estradiol—osteoporosis	0.000817	0.00277	CcSEcCtD
Tolmetin—Abdominal pain—Calcitriol—osteoporosis	0.000815	0.00276	CcSEcCtD
Tolmetin—Body temperature increased—Calcitriol—osteoporosis	0.000815	0.00276	CcSEcCtD
Tolmetin—Thrombocytopenia—Pamidronate—osteoporosis	0.000808	0.00274	CcSEcCtD
Tolmetin—Vomiting—Etidronic acid—osteoporosis	0.000807	0.00273	CcSEcCtD
Tolmetin—Headache—Etidronic acid—osteoporosis	0.000795	0.00269	CcSEcCtD
Tolmetin—Asthenia—Estropipate—osteoporosis	0.000788	0.00267	CcSEcCtD
Tolmetin—Visual impairment—Estradiol—osteoporosis	0.000788	0.00267	CcSEcCtD
Tolmetin—Chest pain—Zoledronate—osteoporosis	0.000786	0.00266	CcSEcCtD
Tolmetin—Asthenia—Alendronate—osteoporosis	0.000776	0.00263	CcSEcCtD
Tolmetin—Erythema multiforme—Estradiol—osteoporosis	0.000773	0.00262	CcSEcCtD
Tolmetin—Dyspepsia—Risedronate—osteoporosis	0.000764	0.00259	CcSEcCtD
Tolmetin—Tinnitus—Estradiol—osteoporosis	0.000762	0.00258	CcSEcCtD
Tolmetin—Constipation—Ethinyl Estradiol—osteoporosis	0.000761	0.00258	CcSEcCtD
Tolmetin—Chest pain—Conjugated Estrogens—osteoporosis	0.000757	0.00256	CcSEcCtD
Tolmetin—Asthenia—Ibandronate—osteoporosis	0.000756	0.00256	CcSEcCtD
Tolmetin—Nausea—Etidronic acid—osteoporosis	0.000754	0.00255	CcSEcCtD
Tolmetin—Anaphylactic shock—Zoledronate—osteoporosis	0.000754	0.00255	CcSEcCtD
Tolmetin—Oedema—Zoledronate—osteoporosis	0.000754	0.00255	CcSEcCtD
Tolmetin—Diarrhoea—Estropipate—osteoporosis	0.000751	0.00254	CcSEcCtD
Tolmetin—Constipation—Risedronate—osteoporosis	0.000742	0.00251	CcSEcCtD
Tolmetin—Diarrhoea—Alendronate—osteoporosis	0.00074	0.00251	CcSEcCtD
Tolmetin—Asthenia—Calcitriol—osteoporosis	0.00074	0.0025	CcSEcCtD
Tolmetin—Thrombocytopenia—Zoledronate—osteoporosis	0.000738	0.0025	CcSEcCtD
Tolmetin—Somnolence—Pamidronate—osteoporosis	0.000733	0.00248	CcSEcCtD
Tolmetin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000728	0.00246	CcSEcCtD
Tolmetin—Diarrhoea—Raloxifene—osteoporosis	0.000728	0.00246	CcSEcCtD
Tolmetin—Dyspepsia—Pamidronate—osteoporosis	0.000726	0.00246	CcSEcCtD
Tolmetin—Dizziness—Estropipate—osteoporosis	0.000726	0.00246	CcSEcCtD
Tolmetin—Oedema—Conjugated Estrogens—osteoporosis	0.000726	0.00246	CcSEcCtD
Tolmetin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000726	0.00246	CcSEcCtD
Tolmetin—Diarrhoea—Ibandronate—osteoporosis	0.000721	0.00244	CcSEcCtD
Tolmetin—Dizziness—Alendronate—osteoporosis	0.000715	0.00242	CcSEcCtD
Tolmetin—Gastrointestinal pain—Risedronate—osteoporosis	0.00071	0.0024	CcSEcCtD
Tolmetin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000707	0.00239	CcSEcCtD
Tolmetin—Constipation—Pamidronate—osteoporosis	0.000706	0.00239	CcSEcCtD
Tolmetin—Diarrhoea—Calcitriol—osteoporosis	0.000705	0.00239	CcSEcCtD
Tolmetin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000704	0.00238	CcSEcCtD
Tolmetin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000704	0.00238	CcSEcCtD
Tolmetin—Dizziness—Raloxifene—osteoporosis	0.000703	0.00238	CcSEcCtD
Tolmetin—Flatulence—Estradiol—osteoporosis	0.000701	0.00237	CcSEcCtD
Tolmetin—Vomiting—Estropipate—osteoporosis	0.000698	0.00236	CcSEcCtD
Tolmetin—Dizziness—Ibandronate—osteoporosis	0.000696	0.00236	CcSEcCtD
Tolmetin—Urticaria—Risedronate—osteoporosis	0.000689	0.00233	CcSEcCtD
Tolmetin—Headache—Estropipate—osteoporosis	0.000688	0.00233	CcSEcCtD
Tolmetin—Vomiting—Alendronate—osteoporosis	0.000688	0.00233	CcSEcCtD
Tolmetin—Abdominal pain—Risedronate—osteoporosis	0.000686	0.00232	CcSEcCtD
Tolmetin—Body temperature increased—Risedronate—osteoporosis	0.000686	0.00232	CcSEcCtD
Tolmetin—Headache—Alendronate—osteoporosis	0.000678	0.00229	CcSEcCtD
Tolmetin—Vomiting—Raloxifene—osteoporosis	0.000676	0.00229	CcSEcCtD
Tolmetin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000675	0.00228	CcSEcCtD
Tolmetin—Somnolence—Zoledronate—osteoporosis	0.00067	0.00227	CcSEcCtD
Tolmetin—Vomiting—Ibandronate—osteoporosis	0.00067	0.00227	CcSEcCtD
Tolmetin—Headache—Raloxifene—osteoporosis	0.000666	0.00226	CcSEcCtD
Tolmetin—Dyspepsia—Zoledronate—osteoporosis	0.000663	0.00225	CcSEcCtD
Tolmetin—Headache—Ibandronate—osteoporosis	0.00066	0.00223	CcSEcCtD
Tolmetin—Vomiting—Calcitriol—osteoporosis	0.000655	0.00222	CcSEcCtD
Tolmetin—Nausea—Estropipate—osteoporosis	0.000652	0.00221	CcSEcCtD
Tolmetin—Abdominal pain—Pamidronate—osteoporosis	0.000652	0.00221	CcSEcCtD
Tolmetin—Body temperature increased—Pamidronate—osteoporosis	0.000652	0.00221	CcSEcCtD
Tolmetin—Headache—Calcitriol—osteoporosis	0.000646	0.00219	CcSEcCtD
Tolmetin—Somnolence—Conjugated Estrogens—osteoporosis	0.000645	0.00218	CcSEcCtD
Tolmetin—Constipation—Zoledronate—osteoporosis	0.000644	0.00218	CcSEcCtD
Tolmetin—Nausea—Alendronate—osteoporosis	0.000642	0.00218	CcSEcCtD
Tolmetin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000639	0.00216	CcSEcCtD
Tolmetin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000639	0.00216	CcSEcCtD
Tolmetin—Nausea—Raloxifene—osteoporosis	0.000632	0.00214	CcSEcCtD
Tolmetin—Nausea—Ibandronate—osteoporosis	0.000626	0.00212	CcSEcCtD
Tolmetin—Asthenia—Risedronate—osteoporosis	0.000623	0.00211	CcSEcCtD
Tolmetin—Constipation—Conjugated Estrogens—osteoporosis	0.000621	0.0021	CcSEcCtD
Tolmetin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000616	0.00209	CcSEcCtD
Tolmetin—Nausea—Calcitriol—osteoporosis	0.000612	0.00207	CcSEcCtD
Tolmetin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000609	0.00206	CcSEcCtD
Tolmetin—Chest pain—Estradiol—osteoporosis	0.000606	0.00205	CcSEcCtD
Tolmetin—Urticaria—Zoledronate—osteoporosis	0.000599	0.00203	CcSEcCtD
Tolmetin—Abdominal pain—Zoledronate—osteoporosis	0.000596	0.00202	CcSEcCtD
Tolmetin—Body temperature increased—Zoledronate—osteoporosis	0.000596	0.00202	CcSEcCtD
Tolmetin—Diarrhoea—Risedronate—osteoporosis	0.000594	0.00201	CcSEcCtD
Tolmetin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000593	0.00201	CcSEcCtD
Tolmetin—Asthenia—Pamidronate—osteoporosis	0.000592	0.002	CcSEcCtD
Tolmetin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000589	0.00199	CcSEcCtD
Tolmetin—Anaphylactic shock—Estradiol—osteoporosis	0.000581	0.00197	CcSEcCtD
Tolmetin—Oedema—Estradiol—osteoporosis	0.000581	0.00197	CcSEcCtD
Tolmetin—Urticaria—Conjugated Estrogens—osteoporosis	0.000576	0.00195	CcSEcCtD
Tolmetin—Dizziness—Risedronate—osteoporosis	0.000574	0.00194	CcSEcCtD
Tolmetin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000574	0.00194	CcSEcCtD
Tolmetin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000574	0.00194	CcSEcCtD
Tolmetin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000566	0.00192	CcSEcCtD
Tolmetin—Diarrhoea—Pamidronate—osteoporosis	0.000565	0.00191	CcSEcCtD
Tolmetin—Headache—Ethinyl Estradiol—osteoporosis	0.000558	0.00189	CcSEcCtD
Tolmetin—Vomiting—Risedronate—osteoporosis	0.000552	0.00187	CcSEcCtD
Tolmetin—Dizziness—Pamidronate—osteoporosis	0.000546	0.00185	CcSEcCtD
Tolmetin—Headache—Risedronate—osteoporosis	0.000544	0.00184	CcSEcCtD
Tolmetin—Asthenia—Zoledronate—osteoporosis	0.000541	0.00183	CcSEcCtD
Tolmetin—Nausea—Ethinyl Estradiol—osteoporosis	0.000529	0.00179	CcSEcCtD
Tolmetin—Vomiting—Pamidronate—osteoporosis	0.000525	0.00178	CcSEcCtD
Tolmetin—Asthenia—Conjugated Estrogens—osteoporosis	0.000521	0.00176	CcSEcCtD
Tolmetin—Headache—Pamidronate—osteoporosis	0.000517	0.00175	CcSEcCtD
Tolmetin—Somnolence—Estradiol—osteoporosis	0.000516	0.00175	CcSEcCtD
Tolmetin—Diarrhoea—Zoledronate—osteoporosis	0.000516	0.00175	CcSEcCtD
Tolmetin—Nausea—Risedronate—osteoporosis	0.000516	0.00175	CcSEcCtD
Tolmetin—Dyspepsia—Estradiol—osteoporosis	0.000511	0.00173	CcSEcCtD
Tolmetin—Dizziness—Zoledronate—osteoporosis	0.000498	0.00169	CcSEcCtD
Tolmetin—Constipation—Estradiol—osteoporosis	0.000497	0.00168	CcSEcCtD
Tolmetin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000496	0.00168	CcSEcCtD
Tolmetin—Nausea—Pamidronate—osteoporosis	0.00049	0.00166	CcSEcCtD
Tolmetin—Dizziness—Conjugated Estrogens—osteoporosis	0.00048	0.00162	CcSEcCtD
Tolmetin—Vomiting—Zoledronate—osteoporosis	0.000479	0.00162	CcSEcCtD
Tolmetin—Gastrointestinal pain—Estradiol—osteoporosis	0.000475	0.00161	CcSEcCtD
Tolmetin—Headache—Zoledronate—osteoporosis	0.000472	0.0016	CcSEcCtD
Tolmetin—Vomiting—Conjugated Estrogens—osteoporosis	0.000461	0.00156	CcSEcCtD
Tolmetin—Urticaria—Estradiol—osteoporosis	0.000461	0.00156	CcSEcCtD
Tolmetin—Body temperature increased—Estradiol—osteoporosis	0.000459	0.00155	CcSEcCtD
Tolmetin—Abdominal pain—Estradiol—osteoporosis	0.000459	0.00155	CcSEcCtD
Tolmetin—Headache—Conjugated Estrogens—osteoporosis	0.000455	0.00154	CcSEcCtD
Tolmetin—Nausea—Zoledronate—osteoporosis	0.000448	0.00152	CcSEcCtD
Tolmetin—Nausea—Conjugated Estrogens—osteoporosis	0.000431	0.00146	CcSEcCtD
Tolmetin—Asthenia—Estradiol—osteoporosis	0.000417	0.00141	CcSEcCtD
Tolmetin—Diarrhoea—Estradiol—osteoporosis	0.000397	0.00135	CcSEcCtD
Tolmetin—CXCL8—GPCR downstream signaling—CALCR—osteoporosis	0.000391	0.0026	CbGpPWpGaD
Tolmetin—Dizziness—Estradiol—osteoporosis	0.000384	0.0013	CcSEcCtD
Tolmetin—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	0.000376	0.0025	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—IL6—osteoporosis	0.000371	0.00247	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TPI1—osteoporosis	0.00037	0.00246	CbGpPWpGaD
Tolmetin—Vomiting—Estradiol—osteoporosis	0.000369	0.00125	CcSEcCtD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—osteoporosis	0.000365	0.00243	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTH—osteoporosis	0.000364	0.00242	CbGpPWpGaD
Tolmetin—Headache—Estradiol—osteoporosis	0.000364	0.00123	CcSEcCtD
Tolmetin—CXCL8—TSLP Signaling Pathway—IL6—osteoporosis	0.000361	0.0024	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTH1R—osteoporosis	0.000356	0.00236	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CALCR—osteoporosis	0.000356	0.00236	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CNR2—osteoporosis	0.000355	0.00235	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—MYC—osteoporosis	0.000349	0.00232	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—TGFB1—osteoporosis	0.000349	0.00231	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—P4HB—osteoporosis	0.000348	0.00231	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000347	0.00231	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—RPL24—osteoporosis	0.000347	0.00231	CbGpPWpGaD
Tolmetin—Nausea—Estradiol—osteoporosis	0.000345	0.00117	CcSEcCtD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000344	0.00229	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GAPDH—osteoporosis	0.000342	0.00227	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—WNT1—osteoporosis	0.000333	0.00221	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—RAP1A—osteoporosis	0.000333	0.00221	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL1B—osteoporosis	0.000332	0.0022	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	0.000327	0.00217	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000326	0.00217	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL1B—osteoporosis	0.000324	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TGFB1—osteoporosis	0.000316	0.0021	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	0.000314	0.00209	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	0.000313	0.00208	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—ADCY5—osteoporosis	0.000312	0.00207	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—MGLL—osteoporosis	0.000311	0.00207	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000311	0.00206	CbGpPWpGaD
Tolmetin—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000306	0.00203	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000305	0.00203	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—TLN1—osteoporosis	0.000305	0.00203	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—PTHLH—osteoporosis	0.000302	0.002	CbGpPWpGaD
Tolmetin—CXCL8—ATF-2 transcription factor network—IL6—osteoporosis	0.000301	0.002	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	0.000299	0.00198	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—SOD2—osteoporosis	0.000297	0.00197	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—osteoporosis	0.000295	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL1B—osteoporosis	0.000295	0.00196	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—IL6—osteoporosis	0.000295	0.00196	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—REN—osteoporosis	0.000293	0.00195	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—GPX1—osteoporosis	0.000283	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—MGLL—osteoporosis	0.000282	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—TGFB1—osteoporosis	0.00028	0.00186	CbGpPWpGaD
Tolmetin—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000278	0.00185	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000276	0.00183	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000273	0.00181	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—POMC—osteoporosis	0.000272	0.00181	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.00027	0.0018	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ENO1—osteoporosis	0.000269	0.00179	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000266	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CALCA—osteoporosis	0.000265	0.00176	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PSMA2—osteoporosis	0.000265	0.00176	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—PSMA5—osteoporosis	0.000265	0.00176	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—IL6—osteoporosis	0.000263	0.00174	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL1B—osteoporosis	0.000259	0.00172	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000259	0.00172	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000254	0.00168	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—TGFB1—osteoporosis	0.000252	0.00167	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000247	0.00164	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—osteoporosis	0.000241	0.0016	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000236	0.00157	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SOST—osteoporosis	0.000232	0.00154	CbGpPWpGaD
Tolmetin—CXCL8—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.000231	0.00154	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—MYC—osteoporosis	0.00023	0.00153	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TGFB1—osteoporosis	0.00023	0.00152	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—POMC—osteoporosis	0.000229	0.00152	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000217	0.00144	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CYP19A1—osteoporosis	0.000215	0.00143	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—osteoporosis	0.000214	0.00142	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000214	0.00142	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTH1R—osteoporosis	0.00021	0.00139	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CALCR—osteoporosis	0.00021	0.00139	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000206	0.00137	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTH—osteoporosis	0.000206	0.00137	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.000203	0.00135	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000201	0.00134	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CNR2—osteoporosis	0.0002	0.00133	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000199	0.00132	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000198	0.00131	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000196	0.0013	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—IL6—osteoporosis	0.000194	0.00129	CbGpPWpGaD
Tolmetin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL6—osteoporosis	0.00019	0.00126	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—IL6—osteoporosis	0.00019	0.00126	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—osteoporosis	0.000188	0.00125	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTH—osteoporosis	0.000187	0.00124	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000187	0.00124	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ACE—osteoporosis	0.000183	0.00122	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000182	0.00121	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CNR2—osteoporosis	0.000182	0.00121	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—ADCY5—osteoporosis	0.000176	0.00117	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GPX1—osteoporosis	0.000175	0.00116	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—IL6—osteoporosis	0.000173	0.00115	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000171	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—WNT1—osteoporosis	0.000171	0.00114	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—PTHLH—osteoporosis	0.00017	0.00113	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000168	0.00112	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MGLL—osteoporosis	0.000167	0.00111	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000164	0.00109	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LRP5—osteoporosis	0.000163	0.00108	CbGpPWpGaD
Tolmetin—PTGS1—Biological oxidations—POMC—osteoporosis	0.000162	0.00108	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—MTHFR—osteoporosis	0.000162	0.00107	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000157	0.00104	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LRP6—osteoporosis	0.000156	0.00103	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—PTHLH—osteoporosis	0.000155	0.00103	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PKM—osteoporosis	0.000153	0.00102	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—FDPS—osteoporosis	0.000153	0.00102	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—osteoporosis	0.000152	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CALCA—osteoporosis	0.00015	0.000996	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.00015	0.000993	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPD2—osteoporosis	0.000145	0.000965	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PGLS—osteoporosis	0.000145	0.000965	CbGpPWpGaD
Tolmetin—PTGS2—Disease—SOST—osteoporosis	0.000145	0.000965	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PKM—osteoporosis	0.000145	0.000965	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—POMC—osteoporosis	0.000139	0.000922	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000138	0.000919	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ANTXR2—osteoporosis	0.000138	0.000914	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PGLS—osteoporosis	0.000138	0.000914	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CALCA—osteoporosis	0.000136	0.000905	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000133	0.000886	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ATIC—osteoporosis	0.000133	0.000882	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PNP—osteoporosis	0.000133	0.000882	CbGpPWpGaD
Tolmetin—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	0.000132	0.000878	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000132	0.000875	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TLN1—osteoporosis	0.000132	0.000873	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	0.000129	0.000859	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—POMC—osteoporosis	0.000129	0.000858	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—FDPS—osteoporosis	0.000122	0.000808	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PKM—osteoporosis	0.000122	0.000808	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	0.000121	0.000801	CbGpPWpGaD
Tolmetin—CXCL8—Cellular Senescence—IL6—osteoporosis	0.00012	0.000798	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	0.000119	0.000788	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GSN—osteoporosis	0.000117	0.000778	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPD2—osteoporosis	0.000115	0.000766	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PGLS—osteoporosis	0.000115	0.000766	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000114	0.000758	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—LEP—osteoporosis	0.000114	0.000755	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—P4HB—osteoporosis	0.000113	0.000753	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CA2—osteoporosis	0.000113	0.00075	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—OXCT1—osteoporosis	0.000113	0.00075	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTH—osteoporosis	0.00011	0.000733	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MGLL—osteoporosis	0.00011	0.000731	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAP1A—osteoporosis	0.000108	0.00072	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CNR2—osteoporosis	0.000108	0.000714	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ADCY5—osteoporosis	0.000107	0.000709	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—NFATC1—osteoporosis	0.000106	0.000702	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ATIC—osteoporosis	0.000105	0.0007	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PNP—osteoporosis	0.000105	0.0007	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—DKK1—osteoporosis	0.000105	0.000697	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000104	0.000689	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LRP5—osteoporosis	0.000102	0.000676	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—WNT1—osteoporosis	0.000101	0.000671	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—MYC—osteoporosis	0.000101	0.000669	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	0.000101	0.000668	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.97e-05	0.000662	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGA—osteoporosis	9.83e-05	0.000653	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—POMC—osteoporosis	9.77e-05	0.000649	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LRP6—osteoporosis	9.74e-05	0.000647	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ADCY5—osteoporosis	9.69e-05	0.000644	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	9.58e-05	0.000636	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—IGF1—osteoporosis	9.4e-05	0.000624	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—osteoporosis	9.39e-05	0.000623	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—IDH2—osteoporosis	9.36e-05	0.000622	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RPL24—osteoporosis	9.36e-05	0.000622	CbGpPWpGaD
Tolmetin—PTGS2—Disease—LTF—osteoporosis	9.36e-05	0.000622	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PTHLH—osteoporosis	9.14e-05	0.000607	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—BMP2—osteoporosis	9.14e-05	0.000607	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—IL6—osteoporosis	9.08e-05	0.000603	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—OXCT1—osteoporosis	8.97e-05	0.000596	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CA2—osteoporosis	8.97e-05	0.000596	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—FGB—osteoporosis	8.95e-05	0.000594	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP27A1—osteoporosis	8.8e-05	0.000584	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MGLL—osteoporosis	8.74e-05	0.00058	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSMA5—osteoporosis	8.64e-05	0.000573	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSMA2—osteoporosis	8.64e-05	0.000573	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ACP5—osteoporosis	8.56e-05	0.000569	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.45e-05	0.000561	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	8.24e-05	0.000547	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ACP5—osteoporosis	8.12e-05	0.000539	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CALCA—osteoporosis	8.05e-05	0.000534	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TPI1—osteoporosis	7.96e-05	0.000529	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—POMC—osteoporosis	7.85e-05	0.000521	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—IL6—osteoporosis	7.58e-05	0.000503	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TPI1—osteoporosis	7.55e-05	0.000501	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—P4HB—osteoporosis	7.48e-05	0.000497	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—IDH2—osteoporosis	7.43e-05	0.000494	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GAPDH—osteoporosis	7.35e-05	0.000488	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—KL—osteoporosis	7.31e-05	0.000485	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—RAP1A—osteoporosis	7.15e-05	0.000475	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—POMC—osteoporosis	7.13e-05	0.000473	CbGpPWpGaD
Tolmetin—PTGS2—Disease—P4HB—osteoporosis	7.09e-05	0.000471	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP27A1—osteoporosis	6.99e-05	0.000464	CbGpPWpGaD
Tolmetin—PTGS2—Disease—GAPDH—osteoporosis	6.96e-05	0.000462	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6R—osteoporosis	6.95e-05	0.000462	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.86e-05	0.000455	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.84e-05	0.000454	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ACP5—osteoporosis	6.8e-05	0.000451	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.71e-05	0.000446	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NFATC1—osteoporosis	6.62e-05	0.000439	CbGpPWpGaD
Tolmetin—PTGS2—Disease—DKK1—osteoporosis	6.56e-05	0.000436	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.39e-05	0.000424	CbGpPWpGaD
Tolmetin—PTGS2—Disease—WNT1—osteoporosis	6.32e-05	0.00042	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TPI1—osteoporosis	6.32e-05	0.00042	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.24e-05	0.000414	CbGpPWpGaD
Tolmetin—PTGS2—Disease—FGA—osteoporosis	6.15e-05	0.000408	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—P4HB—osteoporosis	5.94e-05	0.000395	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GAPDH—osteoporosis	5.83e-05	0.000387	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ENO1—osteoporosis	5.78e-05	0.000384	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADCY5—osteoporosis	5.72e-05	0.00038	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMA2—osteoporosis	5.7e-05	0.000378	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—PSMA5—osteoporosis	5.7e-05	0.000378	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—RAP1A—osteoporosis	5.68e-05	0.000377	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—SPP1—osteoporosis	5.54e-05	0.000368	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ENO1—osteoporosis	5.48e-05	0.000364	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMA2—osteoporosis	5.4e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSMA5—osteoporosis	5.4e-05	0.000359	CbGpPWpGaD
Tolmetin—PTGS2—Disease—CALCA—osteoporosis	5.03e-05	0.000334	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS2—osteoporosis	5.01e-05	0.000333	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.95e-05	0.000329	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—LEP—osteoporosis	4.9e-05	0.000325	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ESR1—osteoporosis	4.68e-05	0.000311	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CYP19A1—osteoporosis	4.62e-05	0.000307	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ENO1—osteoporosis	4.59e-05	0.000305	CbGpPWpGaD
Tolmetin—PTGS2—Disease—KL—osteoporosis	4.57e-05	0.000304	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMA2—osteoporosis	4.52e-05	0.0003	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—PSMA5—osteoporosis	4.52e-05	0.0003	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IRS1—osteoporosis	4.37e-05	0.00029	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—POMC—osteoporosis	4.21e-05	0.00028	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6R—osteoporosis	4.11e-05	0.000273	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IGF1—osteoporosis	4.05e-05	0.000269	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ADCY5—osteoporosis	3.78e-05	0.000251	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX1—osteoporosis	3.76e-05	0.00025	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CYP19A1—osteoporosis	3.67e-05	0.000244	CbGpPWpGaD
Tolmetin—PTGS2—Disease—ADCY5—osteoporosis	3.58e-05	0.000238	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—MTHFR—osteoporosis	3.47e-05	0.000231	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MTHFR—osteoporosis	3.29e-05	0.000219	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS2—osteoporosis	3.13e-05	0.000208	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—IL6—osteoporosis	3.1e-05	0.000206	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ADCY5—osteoporosis	3e-05	0.000199	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX1—osteoporosis	2.99e-05	0.000198	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—POMC—osteoporosis	2.78e-05	0.000185	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—MTHFR—osteoporosis	2.76e-05	0.000183	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IRS1—osteoporosis	2.74e-05	0.000182	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6R—osteoporosis	2.57e-05	0.000171	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—MYC—osteoporosis	2.43e-05	0.000162	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—TGFB1—osteoporosis	2.43e-05	0.000161	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—POMC—osteoporosis	2.21e-05	0.000146	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—IL6—osteoporosis	1.83e-05	0.000122	CbGpPWpGaD
Tolmetin—PTGS2—Disease—MYC—osteoporosis	1.52e-05	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—TGFB1—osteoporosis	1.52e-05	0.000101	CbGpPWpGaD
Tolmetin—PTGS2—Disease—IL6—osteoporosis	1.14e-05	7.6e-05	CbGpPWpGaD
